Novo Nordisk develops new mechanical insulin pill with star researchers from MIT
Novo Nordisk has developed a new pill technology, the future basis for an insulin pill, in collaboration with star researcher Robert Langer and his team at MIT. The company expects clinical studies to take place in two to three years.
BY KEVIN GRØNNEMANN
It was to the “deep frustration” of research director Mads Krogsgaard Thomsen that Novo Nordisk gave up on a year long project to develop an insulin pill, that would have given type 1 diabetics a needle-free alternative, in 2016.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
.jpg&w=384&q=75)
